Interleukin-10 (IL-10) is a cytokine which has been suggested as a possible
immunosuppressive treatment for kidney disease. The ability of IL-10 to su
ppress antigen presentation to T cells, inhibit the delayed-type hypersensi
tivity reaction and to inhibit macrophage production of pro-inflammatory cy
tokines provides a logical basis for its use in the treatment of kidney dis
ease. With the exception of Th1-mediated crescentic glomerulonephritis, how
ever, IL-10 treatment of experimental kidney disease has produced disappoin
ting results largely due to its stimulatory effects upon the humoral immune
response, macrophage Fc-receptor expression and macrophage proliferation.
Paradoxically, there is now evidence to suggest that endogenous production
of IL-10 within the kidney may actually contribute to kidney damage through
stimulating mesangial proliferation, immune complex deposition and macroph
age infiltration. We await the outcome of studies designed to block IL-10 f
unction in experimental disease models.